(2S,4R)-1-[(2S)-2-acetamido-3-methylbutanoyl]-4-hydroxy-N-[(1S)-3-(methylamino)-3-oxo-1-phenylpropyl]pyrrolidine-2-carboxamide is a selective ligand for the von Hippel-Lindau (VHL) E3 ubiquitin ligase. As an advanced E3 ligase ligand, it plays a critical role in PROTAC (Proteolysis Targeting Chimera) drug development, enabling targeted degradation of disease-driving proteins. This compound serves as an essential building block for designing VHL-based PROTACs, which induce the proximity of target proteins to the cell's ubiquitin-proteasome system for selective degradation. VHL ligands like this are widely used for degrading kinases, transcription factors, and other challenging targets in cancer and other diseases, accelerating next-generation therapeutics research.
Structure of 2666951-76-2
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(2S,4R)-1-[(2S)-2-acetamido-3-methylbutanoyl]-4-hydroxy-N-[(1S)-3-(methylamino)-3-oxo-1-phenylpropyl]pyrrolidine-2-carboxamide is a synthetic peptide-based ligand specifically engineered for binding to the von Hippel-Lindau (VHL) E3 ubiquitin ligase. VHL ligands play a critical role in the design and synthesis of PROTAC (Proteolysis Targeting Chimera) molecules, enabling targeted protein degradation and helping researchers develop next-generation therapies for cancer, neurodegeneration, and other diseases. This peptide VHL ligand features high binding affinity and selectivity, providing a reliable building block for bifunctional degrader molecules.
Mechanism
This VHL ligand mimics natural HIF-1α peptide motifs, enabling high-affinity binding to the VHL E3 ubiquitin ligase complex (CRL2VHL). When integrated into a PROTAC molecule, the ligand brings VHL in close proximity to a target protein, which is simultaneously engaged by a target ligand. This proximity triggers ubiquitination of the target protein, leading to its recognition and subsequent degradation by the 26S proteasome. The specificity and high affinity of the VHL ligand are essential for efficient and selective targeted protein degradation.
Applications
(2S,4R)-1-[(2S)-2-acetamido-3-methylbutanoyl]-4-hydroxy-N-[(1S)-3-(methylamino)-3-oxo-1-phenylpropyl]pyrrolidine-2-carboxamide is widely used in drug discovery programs employing VHL-recruiting PROTAC platforms. Its optimized peptide structure supports robust conjugation to a variety of linkers and target ligands, enabling rapid synthesis and screening of novel PROTACs. Key applications include:
• Synthesis of VHL-based PROTAC molecules for targeted degradation of disease-associated proteins
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.